Parsons slashes FY26 guidance after Q2 miss, stock plunges 35%

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Parsons Corporation reported a Q2 adjusted loss per share of $0.06 and revenue of $1.576 billion, missing consensus estimates. The company cut FY26 revenue guidance to $6.2-$6.5 billion and adjusted EBITDA to $500-$560 million due to a canceled federal contract and divestitures. Analysts lowered price targets, with Truist Securities citing a valuation discount to peers despite strong book-to-bill ratios.

powered bylight_fuzz_icon
46986548

*this image is generated using AI for illustrative purposes only.

Parsons Corporation (NYSE: PSN) shares plunged 35% following a sharp reduction in its full-year 2026 financial guidance and a weaker-than-expected second-quarter performance. The engineering and construction firm reported an adjusted loss per share of $0.06 for the quarter ended June 30, 2026, missing analyst consensus estimates of $0.76. Revenue came in at $1.576 billion, falling short of the $1.617 billion consensus and declining 1% year over year. The company lowered its FY26 revenue guidance to $6.2-$6.5 billion from $6.5-$6.8 billion and cut adjusted EBITDA guidance to $500-$560 million from $615-$675 million, citing a canceled fixed-price government contract and portfolio divestitures.

The guidance adjustment was disclosed via Form 8-K filed with regulators on July 29, 2026. Management attributed the shortfall to "planned divestitures," "lower pass-through costs," and "federal contract timing." A primary driver was a confidential fixed-price contract that was "canceled by the administration," which had generated $50 million in revenue in the quarter ended November 30, 2025. Chair, President and CEO Carey Smith noted that the company is "basically demobilizing" from this program. Additionally, operating income fell 99% year over year to $1 million due to losses from programs targeted for divestiture and charges related to a joint venture program.

Financial Impact and Operational Shortfalls

The financial deterioration is evident in the latest quarterly results, which underscore the severity of the operational headwinds. Reported adjusted EBITDA for the most recent quarter stood at approximately $42 million, representing a roughly 72% decline year over year. Alongside this operating metric contraction, the company reported a net loss of about $15 million for the period. These figures highlight the immediate impact of the canceled contract and broader timing issues within its federal business lines.

Metric Previous Guidance / Prior Period Revised Guidance / Current Period Change
FY26 Revenue Guidance $6.5-$6.8 billion $6.2-$6.5 billion Lowered
FY26 Adj. EBITDA Guidance $615-$675 million $500-$560 million Down to $115 million
Q2 FY26 Revenue N/A $1.576 billion Missed Consensus
Q2 FY26 Adj. EPS N/A ($0.06) Loss Missed Consensus

Despite the headwinds, Parsons witnessed a 24% year-over-year increase in contract awards and a 1.2x book-to-bill ratio for the quarter. The company also highlighted 10% organic revenue growth in the Middle East and a 1.1x book-to-bill ratio in that region, alongside "portfolio-shaping" actions aimed at prioritizing profitable, sustainable growth.

Analyst Reactions and Technical Outlook

Following the earnings release, several analysts trimmed their price forecasts for Parsons. UBS lowered its target to $58.00, Citigroup to $53.00, and Stifel to $66.00, all maintaining Buy ratings. Truist Securities analyst Tobey Sommer reiterated a Buy rating but lowered the price forecast from $75 to $60, citing an 18% cut in EBITDA guidance. Sommer noted that Parsons now trades at an estimated 10% discount to peers, compared to a historical 20% premium, expecting this gap to narrow given exposure to high-priority defense areas.

Technically, PSN remains under pressure, trading 31.7% below its 200-day SMA of $63.37 and 20.9% below the 20-day SMA of $54.76. Key resistance sits at $54.94 (50-day SMA), while key support is at $56.26, the 52-week low zone. The stock’s momentum indicators, including MACD, remain negative, suggesting continued downside risk unless buyers reassert control near support levels.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the divestiture of underperforming assets impact Parsons' long-term revenue mix and margin profile once the transition period concludes?

What specific strategies is management implementing to offset the loss of the canceled fixed-price government contract in the remaining quarters of FY26?

Can Parsons sustain its 24% year-over-year growth in new contract awards given the current headwinds in federal spending and timing delays?

like20
dislike

UBS Maintains Buy on Parsons, Lowers Price Target to $58

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights

UBS analyst Gavin Parsons keeps a Buy rating on Parsons Corp (NYSE: PSN) but cuts the price target from $67 to $58. The adjustment reflects a revised valuation while maintaining confidence in the company's long-term investment case.

powered bylight_fuzz_icon
46991413

*this image is generated using AI for illustrative purposes only.

UBS analyst Gavin Parsons maintains a Buy rating on Parsons Corp (NYSE: PSN) but has lowered the price target from $67 to $58. The adjustment signals a recalibration of valuation expectations for the engineering and construction services firm, though the analyst retains a positive long-term outlook on the company’s prospects. This change in price target is significant for investors tracking institutional sentiment, as it narrows the upside potential from the current market levels while keeping the stock within the 'Buy' category. The move suggests that while the fundamental thesis remains intact, near-term catalysts or macroeconomic factors have prompted a more conservative valuation ceiling.

Analyst Action Details

The revision was issued by UBS, a major global financial services institution, with Gavin Parsons serving as the lead analyst for the coverage. The previous price target of $67 implied a higher growth trajectory or margin expansion potential, which has now been tempered to $58. Despite the reduction, the maintenance of the Buy rating indicates that UBS still views Parsons as an attractive investment relative to its peers and broader market indices. Investors should note that price target adjustments are common as analysts incorporate new earnings data, guidance changes, or sector-wide shifts into their models.

Metric Previous Value New Value
Rating Buy Buy
Price Target $67 $58

Market Implications

For shareholders, the lowered price target reduces the theoretical upside gain available from current trading prices. However, the retention of the Buy rating suggests that UBS does not perceive any fundamental deterioration in Parsons’ business model, order book, or competitive positioning. The firm continues to benefit from trends in infrastructure spending and energy transition projects, which likely underpin the continued positive recommendation. Traders may view the cut as a signal of short-term volatility or profit-taking opportunities, while long-term holders might interpret the maintained rating as confirmation of the stock’s resilience.

What the Numbers Show

The drop from $67 to $58 represents a decrease of approximately 13.4% in the analyst’s fair value estimate. While the source does not specify the exact drivers behind this revision, such adjustments often correlate with changes in revenue forecasts, margin assumptions, or discount rate inputs in discounted cash flow models. The fact that the rating was not downgraded to Hold or Sell implies that the core operational metrics remain strong enough to justify ownership, even if the peak valuation has been moderated. This divergence between rating stability and target reduction highlights a nuanced view where growth is expected but at a slightly slower pace than previously anticipated.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific macroeconomic factors or sector-wide shifts prompted UBS to lower the price target while maintaining a Buy rating?

How might this 13.4% reduction in fair value estimate impact Parsons Corp's near-term trading volatility and investor sentiment?

Are there indications that Parsons Corp's infrastructure and energy transition project pipelines are facing delays or margin pressures?

like18
dislike

More News on Parsons